Literature DB >> 26668638

Epidemiology and clinical features of segmental/lobar pattern Mycoplasma pneumoniae pneumonia: A ten-year retrospective clinical study.

Jian Gao1, Baozhu Yue1, Haitao Li2, Rong Chen1, Chunlian Wu1, Mili Xiao3.   

Abstract

Mycoplasma pneumoniae plays an important role in community-acquired pneumonia. However, epidemiological and clinical studies on the segmental/lobar pattern (S/L) radiographic-pathologic subtype of pediatric Mycoplasma pneumoniae pneumonia (MPP) are rare. The current study retrospectively analyzed the epidemiological and clinical characteristics of pediatric MPP patients. A total of 1,933 children with MPP received treatment at a single hospital between 2000 and 2009, of which 684 (35.4%) were diagnosed with S/L-MPP. The annual incidence of S/L-MPP in children with MPP increased throughout the duration of this study (from 6.4 to 59.6%, P<0.001), which was particularly evident after 2003. S/L-MPP was predominantly found in pre-school-aged children (4-6 years old; 56.6%). Compared with non-S/L-MPP, S/L-MPP was more closely associated with severe manifestations, including higher rates of fever (90.2 vs. 83.3%), pleural effusion (3.9 vs. 1.3%), extrapulmonary manifestations (26.2 vs. 21.2%), abnormal white blood cell counts (65.5 vs. 55.2%), abnormal C-reactive protein levels (30.9 vs. 23.7%) and bacterial co-infection (32.0 vs. 24.9%), as well as longer durations of fever (4.13±4.28 vs. 3.02±2.22 days) and hospitalization (12.70±4.54 vs. 9.22±5.12 days). Older S/L-MPP patients showed higher rates and longer durations of fever and cough; however, they also displayed a lower rate of extrapulmonary manifestations when compared with younger patients. In conclusion, the annual incidence of S/L-MPP has increased in recent years. Pre-school-aged children (4-6 years) with MPP are more likely to display a segmental/lobar pattern, which is associated with more severe clinical manifestations than other MPP infection patterns.

Entities:  

Keywords:  Mycoplasma pneumoniae pneumonia; children; epidemiology; segmental and/or lobar

Year:  2015        PMID: 26668638      PMCID: PMC4665157          DOI: 10.3892/etm.2015.2818

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  33 in total

1.  Spectrum of clinical and radiographic findings in pediatric mycoplasma pneumonia.

Authors:  S D John; J Ramanathan; L E Swischuk
Journal:  Radiographics       Date:  2001 Jan-Feb       Impact factor: 5.333

2.  An unrecognized epidemic of Mycoplasma pneumoniae infection in Vienna.

Authors:  Florian Daxboeck; Claudia C Bauer; Ojan Assadian; Gerold Stanek
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

3.  Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group.

Authors:  B J Marston; J F Plouffe; T M File; B A Hackman; S J Salstrom; H B Lipman; M S Kolczak; R F Breiman
Journal:  Arch Intern Med       Date:  1997 Aug 11-25

Review 4.  Pneumococcal pneumonia: epidemiology and clinical features.

Authors:  T J Marrie
Journal:  Semin Respir Infect       Date:  1999-09

5.  Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance.

Authors:  H M Foy; G E Kenny; R McMahan; A M Mansy; J T Grayston
Journal:  JAMA       Date:  1970-11-30       Impact factor: 56.272

6.  Epidemiological characteristics and meteorological factors of childhood Mycoplasma pneumoniae pneumonia in Hangzhou.

Authors:  Ying-Chun Xu; Lan-Juan Zhu; Dan Xu; Xiao-Fen Tao; Shu-Xian Li; Lan-Fang Tang; Zhi-Min Chen
Journal:  World J Pediatr       Date:  2011-08-07       Impact factor: 2.764

7.  Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia. Mowgli Study Group.

Authors:  S Esposito; F Blasi; F Bellini; L Allegra; N Principi
Journal:  Eur Respir J       Date:  2001-02       Impact factor: 16.671

Review 8.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Epidemiology and clinical features of Mycoplasma pneumoniae infection in children.

Authors:  Annacarla Defilippi; Michela Silvestri; Angela Tacchella; Raffaella Giacchino; Giovanni Melioli; Eddi Di Marco; Carmela Cirillo; Pasquale Di Pietro; Giovanni A Rossi
Journal:  Respir Med       Date:  2008-08-13       Impact factor: 3.415

10.  Epidemiology of severe pneumonia caused by Legionella longbeachae, Mycoplasma pneumoniae, and Chlamydia pneumoniae: 1-year, population-based surveillance for severe pneumonia in Thailand.

Authors:  Christina R Phares; Piyada Wangroongsarb; Somrak Chantra; Wantana Paveenkitiporn; Maria-Lucia Tondella; Robert F Benson; W Lanier Thacker; Barry S Fields; Matthew R Moore; Julie Fischer; Scott F Dowell; Sonja J Olsen
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

View more
  8 in total

Review 1.  Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review.

Authors:  Norishi Ueda; Satoshi Minami; Manabu Akimoto
Journal:  BMC Infect Dis       Date:  2016-11-11       Impact factor: 3.090

2.  Effect of montelukast combined with methylprednisolone for the treatment of mycoplasma pneumonia.

Authors:  Hongtu Wu; Xian Ding; Deyu Zhao; Yong Liang; Wei Ji
Journal:  J Int Med Res       Date:  2019-05-09       Impact factor: 1.671

Review 3.  Comparative efficacy of Chinese herbal injections combined with azithromycin for mycoplasma pneumonia in children: A Bayesian network meta-analysis of randomized controlled trials.

Authors:  Xiaojiao Duan; Kaihuan Wang; Jiarui Wu; Dan Zhang; Xinkui Liu; Mengwei Ni; Shuyu Liu; Ziqi Meng
Journal:  J Clin Pharm Ther       Date:  2019-05-22       Impact factor: 2.512

4.  The clinical characteristics of Mycoplasma pneumoniae pneumonia and its relationship between hypokalemia in west China.

Authors:  Zhoubo Han; Yong Zhang; Shunli Liao; Na Zhou
Journal:  Transl Pediatr       Date:  2021-02

5.  The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia: A meta-analysis.

Authors:  Hui Gong; Baijun Sun; Ye Chen; Huijie Chen
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

6.  Epidemiologic and clinical characteristics of human bocavirus infection in infants and young children suffering with community acquired pneumonia in Ningxia, China.

Authors:  Kai Ji; Jinhan Sun; Yan Yan; Lei Han; Jianhui Guo; Anwen Ma; Xueqi Hao; Fang Li; Yuning Sun
Journal:  Virol J       Date:  2021-10-29       Impact factor: 4.099

7.  A systematic review of the clinical features of pneumonia in children aged 5-9 years: Implications for guidelines and research.

Authors:  Priya M Kevat; Melinda Morpeth; Hamish Graham; Amy Z Gray
Journal:  J Glob Health       Date:  2022-03-26       Impact factor: 4.413

8.  Epidemiology and clinical characteristics of pathogens positive in hospitalized children with segmental/lobar pattern pneumonia.

Authors:  Yanxia Wang; Liji Ma; Ying Li; Yuyun Li; Yanfei Zheng; Xiaoyue Zhang
Journal:  BMC Infect Dis       Date:  2020-03-06       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.